What You Ought to Know:
– Bluesight, a frontrunner in hospital intelligence options launched its 2025 Diversion Developments Report, a complete evaluation highlighting the numerous impression of software program on the monitoring, prevention, and identification of managed substance diversion in healthcare settings.
– The report, which analyzed over 266 million managed substance transactions from greater than 1,100 hospitals and well being programs nationwide, gives essential insights for organizations aiming to boost affected person security and documentation compliance.
Key Developments in Diversion Monitoring
Drug diversion continues to be a essential subject for healthcare amenities throughout the U.S.. Nevertheless, Bluesight’s newest findings point out that the strategic deployment of know-how is resulting in marked enhancements in detection and determination.
The 2025 Diversion Developments Report identifies a number of key highlights:
- Elevated Investigations: Hospitals are leveraging diversion monitoring software program to conduct extra investigations, with a 61% improve in investigations from 2023 to 2024. This progress is primarily pushed by the expanded use of software program options like ControlCheck.
- Sooner Case Closure: Diversion circumstances at the moment are closing 40 days quicker in year-over-year comparisons, a direct results of the growing adoption and effectiveness of software program instruments.
- Declining Variance Fee: Finish-to-end, complete diversion monitoring is proving efficient, with the speed of variances in managed substance transactions persevering with to say no. Solely 6% of transactions reported variances in 2024, suggesting general enhancements in documentation accuracy and compliance. This means that as extra transactions are monitored, a bigger share is precisely documented and auto-closed by software program, decreasing the necessity for guide evaluation.
- Prime Diverted Medicine: Fentanyl stays the highest drug related to variances (24%), adopted by Midazolam (15%) and Hydromorphone (10%).
- Main Settings for Diversion: Nearly all of confirmed drug diversion circumstances happen in nursing settings (67%), adopted by the Working Room (OR) (30%) and Pharmacy settings (3%).
- Built-in Strategy: Most hospitals and well being programs depend on a mix of diversion committees (67%) and software program instruments (53%) to detect and forestall diversion.
For extra data obtain the report right here.
Report Methodology
The 2025 Diversion Developments Report analyzed information from Bluesight’s ControlCheck resolution all through 2024, together with pattern information relationship again to September 2018. The in depth dataset encompasses greater than 266 million managed substance transactions. Extra insights have been drawn from Bluesight’s 2024 Hospital Pharmacy Operations Survey, carried out in February 2025, which gathered responses from 159 pharmacy professionals, 95 of whom are straight concerned in diversion monitoring and prevention.
